Gartner, Inc. Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
Gartner, Inc. (IT) reported Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $48.77 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-22.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2018-02-22
- Gartner, Inc. cash and cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2017-03-31 was $747.65M, a 2564.09% increase year-over-year.
- Gartner, Inc. cash and cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2016-03-31 was $28.06M.
- Gartner, Inc. cash and cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2015-03-31 was -$60.38M.
- Gartner, Inc. cash and cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2014-03-31 was -$140.26M.
- Gartner, Inc. cash and cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2017 was $48.77M, a 54.37% decline from fiscal 2016.
- Gartner, Inc. cash and cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2016 was $106.90M, a 201.00% increase from fiscal 2015.
- Gartner, Inc. cash and cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2015 was $35.51M.
- Gartner, Inc. cash and cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2014 was -$24.67M, a 119.69% decline from fiscal 2013.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2017-12-31 | $48.77M 10-K · filed 2018-02-22 | |||
| 2017-09-30 | $127.41M 10-Q · filed 2017-11-02 | |||
| 2017-06-30 | $104.64M 10-Q · filed 2017-08-08 | |||
| 2017-03-31 | $747.65M 10-Q · filed 2017-05-04 | |||
| 2016-12-31 | $106.90M 10-K · filed 2018-02-22 | |||
| 2016-09-30 | $85.09M 10-Q · filed 2017-11-02 | |||
| 2016-06-30 | $64.31M 10-Q · filed 2017-08-08 | |||
| 2016-03-31 | $28.06M 10-Q · filed 2017-05-04 | |||
| 2015-12-31 | $35.51M 10-K · filed 2018-02-22 | |||
| 2015-09-30 | $33.57M 10-Q · filed 2016-11-03 | |||
| 2015-06-30 | $9.29M 10-Q · filed 2016-08-04 | |||
| 2015-03-31 | -$60.38M 10-Q · filed 2016-05-05 | |||
| 2014-12-31 | -$24.67M 10-K · filed 2017-02-22 | |||
| 2014-09-30 | -$68.28M 10-Q · filed 2015-11-05 | |||
| 2014-06-30 | -$106.39M 10-Q · filed 2015-07-30 | |||
| 2014-03-31 | -$140.26M 10-Q · filed 2015-05-07 | |||
| 2013-12-31 | $125.30M 10-K · filed 2016-02-24 | |||
| 2013-09-30 | $76.44M 10-Q · filed 2014-11-06 | |||
| 2013-06-30 | $39.60M 10-Q · filed 2014-08-05 | |||
| 2013-03-31 | -$26.86M 10-Q · filed 2014-05-01 | |||
| 2012-12-31 | $152.57M 10-K · filed 2015-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evolent Health, Inc. (EVH) | United States | $0.397B | -1.21 |
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |